Interpace Biosciences, Inc.
IDXGD
$6.98
-$0.02-0.29%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 435.46% | 121.32% | 71.46% | -32.65% | -75.14% |
| Total Receivables | -12.72% | -32.42% | -33.88% | -18.20% | 16.52% |
| Inventory | 11.51% | -20.51% | -8.01% | -9.51% | -20.96% |
| Prepaid Expenses | -4.66% | 8.31% | 18.13% | 32.43% | 9.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 176.47% | -- | -- | 23.26% | 58.14% |
| Total Current Assets | 15.40% | -14.51% | -15.91% | -17.82% | -6.51% |
|
|
|||||
| Total Current Assets | 15.40% | -14.51% | -15.91% | -17.82% | -6.51% |
| Net Property, Plant & Equipment | -5.89% | -13.24% | -11.23% | -0.80% | 0.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 46,475.56% | 46,613.33% | 47,228.89% | 0.00% | 0.00% |
| Total Assets | 180.09% | 130.50% | 128.76% | -14.27% | -4.91% |
|
|
|||||
| Total Accounts Payable | 24.40% | -53.55% | -40.75% | -17.05% | -29.02% |
| Total Accrued Expenses | -28.05% | -37.73% | -18.88% | -77.78% | -69.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -78.97% | -85.91% | -90.78% | -76.71% | -69.34% |
| Total Finance Division Other Current Liabilities | 1.47% | -0.42% | 3.55% | -4.13% | -11.52% |
| Total Other Current Liabilities | 1.47% | -0.42% | 3.55% | -4.13% | -11.52% |
| Total Current Liabilities | -30.75% | -54.34% | -51.93% | -68.33% | -62.43% |
|
|
|||||
| Total Current Liabilities | -30.75% | -54.34% | -51.93% | -68.33% | -62.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -47.02% | -41.20% | -36.43% | -27.33% | -24.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.61% | 7.75% | 7.85% | 5.70% | 5.42% |
| Total Liabilities | -16.56% | -31.50% | -32.54% | -51.03% | -46.79% |
|
|
|||||
| Common Stock & APIC | 0.01% | 0.01% | 0.01% | 24.62% | 24.67% |
| Retained Earnings | 10.43% | 10.12% | 10.44% | 4.48% | 4.60% |
| Treasury Stock & Other | -0.43% | -0.43% | -0.88% | -1.27% | -2.22% |
| Total Common Equity | 2,016.24% | 4,065.98% | 1,108.71% | 99.48% | 97.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2,016.24% | 4,065.98% | 1,108.71% | 99.48% | 97.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2,016.24% | 4,065.98% | 1,108.71% | 97.33% | 90.29% |
|
|
|||||